GlassScriptPhysician profile
James R Morgan
NPI 1639478514
$2,212.81
in general payments reported to CMS, 2019-2025
18 companies · $523 in 2025
The $523 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $946 · 2022: $402 · 2023: $20.50 · 2024: $321 · 2025: $523.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $865.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $864.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $588.27 | 2021-2025 | Spravato |
| Abbvie INC. | $428.66 | 2021-2025 | |
| Alkermes, INC. | $399.75 | 2021-2025 | Aristada, Lybalvi |
| Sunovion Pharmaceuticals INC. | $217.11 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $88.47 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $87.49 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $74.20 | 2021 | |
| Tris Pharma INC | $60.17 | 2025 | Dyanavel Xr |
| Axsome Therapeutics, INC. | $57.58 | 2025 | Auvelity |
| Novo Nordisk INC | $43.30 | 2021-2024 | Wegovy |
| Corium, LLC | $30.12 | 2024 | Azstarys |
| Tempus Ai, INC | $25.47 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $25.00 | 2025 | Cobenfy |
| Indivior INC. | $23.37 | 2021 | |
| Avanir Pharmaceuticals, INC. | $20.71 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $15.78 | 2025 | Fanapt |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.08 | 2021 | |
| Eisai INC. | $13.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.